InMed Pharmaceuticals (INM) Other Working Capital Changes (2023 - 2025)

InMed Pharmaceuticals has reported Other Working Capital Changes for 5 years, with the latest figure at -$110066.0 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 1.11% year-over-year to -$110066.0 in Q1 2026; TTM through Mar 2026 was -$442054.0, a 4.42% decrease from a year earlier, with the FY2025 full-year figure at -$429880.0, down 8.17% from the prior year.
• Other Working Capital Changes was -$110066.0 for Q1 2026 at InMed Pharmaceuticals, roughly flat from -$109917.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $495104.0 in Q4 2024, with the low at -$328867.0 in Q3 2024.
• Average Other Working Capital Changes over 3 years is $69588.0, with a median of -$16171.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes plunged 65268.16% in 2023, then jumped 71.17% in 2024.
• Over 5 years, Other Working Capital Changes stood at $471.0 in 2022, then sank by 20142.46% to -$94400.0 in 2023, then fell by 3.2% to -$97418.0 in 2024, then slipped by 12.83% to -$109917.0 in 2025, then retreated by 0.14% to -$110066.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$110066.0 (Q1 2026), -$109917.0 (Q4 2025), and -$107412.0 (Q3 2025), per Business Quant data.